Capula Management’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-1,386
Closed -$235K 896
2022
Q4
$235K Buy
+1,386
New +$251K ﹤0.01% 671
2021
Q4
Sell
-885
Closed -$255K 658
2021
Q3
$255K Buy
+885
New +$227K ﹤0.01% 740

Other funds holding RGEN

Capula Management's RGEN Position: Q1 2023 in Review

Capula Management sold out of Repligen (RGEN) in Q1 2023, closing a stake of 1,386 shares — an estimated $235K sold.

Capula Management first reported a position in RGEN in Q3 2021 and held it in 2 quarters. The position peaked at $255K in Q3 2021. 446 funds tracked by Wall St. Rank hold RGEN as of Q1 2023.

  • Capula Management reported no remaining Repligen position as of Q1 2023 after selling out during the quarter.
  • Capula Management sold 1,386 Repligen shares in Q1 2023, an estimated $235K.
  • Capula Management first reported a position in Repligen in Q3 2021 and held it in 2 quarters.
  • Capula Management's Repligen position peaked at $255K in Q3 2021.
  • 446 funds tracked by Wall St. Rank held Repligen as of Q1 2023.

Based on Capula Management's 13F filing for Q1 2023, filed 10 May 2023.